Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tuparstobart by Incyte for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
Tuparstobart is under clinical development by Incyte and currently in Phase II for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). According...